Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Deferred Taxes (2016 - 2017)

Historic Deferred Taxes for Wave Life Sciences (WVE) over the last 3 years, with Q4 2017 value amounting to $4000.0.

  • Wave Life Sciences' Deferred Taxes rose 10045.66% to $4000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $908000.0, marking a year-over-year increase of 23008.6%. This contributed to the annual value of $908000.0 for FY2017, which is 23008.6% up from last year.
  • Per Wave Life Sciences' latest filing, its Deferred Taxes stood at $4000.0 for Q4 2017, which was up 10045.66% from $772000.0 recorded in Q3 2017.
  • Wave Life Sciences' Deferred Taxes' 5-year high stood at $772000.0 during Q3 2017, with a 5-year trough of -$876000.0 in Q4 2016.
  • Moreover, its 3-year median value for Deferred Taxes was $48500.0 (2015), whereas its average is $20500.0.
  • Within the past 5 years, the most significant YoY rise in Wave Life Sciences' Deferred Taxes was 57708.33% (2017), while the steepest drop was 376000.0% (2017).
  • Over the past 3 years, Wave Life Sciences' Deferred Taxes (Quarter) stood at -$146000.0 in 2015, then crashed by 500.0% to -$876000.0 in 2016, then soared by 100.46% to $4000.0 in 2017.
  • Its Deferred Taxes was $4000.0 in Q4 2017, compared to $772000.0 in Q3 2017 and $325000.0 in Q2 2017.